State Street SPDR S&P Biotech ETF (XBI)
121.46
-1.93 (-1.56%)
NYSE · Last Trade: Dec 30th, 4:02 PM EST

The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.
Via MarketBeat · September 23, 2024

The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.
Via MarketBeat · July 13, 2023

Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility.
Via MarketBeat · March 22, 2023